Your browser doesn't support javascript.
loading
Comprehensive genetic analysis for identification of monogenic disorders and selection of appropriate treatments in pediatric patients with persistent thrombocytopenia.
Sato, Daichi; Kirikae, Hinako; Nakano, Tomohiro; Katayama, Saori; Yaoita, Hisao; Takayama, Jun; Tamiya, Gen; Kure, Shigeo; Kikuchi, Atsuo; Sasahara, Yoji.
Affiliation
  • Sato D; Department of Pediatrics, Tohoku University Graduate School of Medicine, Miyagi, Japan.
  • Kirikae H; Department of Pediatrics, Tohoku University Graduate School of Medicine, Miyagi, Japan.
  • Nakano T; Department of Pediatrics, Tohoku University Graduate School of Medicine, Miyagi, Japan.
  • Katayama S; Department of Pediatrics, Tohoku University Graduate School of Medicine, Miyagi, Japan.
  • Yaoita H; Department of Pediatrics, Tohoku University Graduate School of Medicine, Miyagi, Japan.
  • Takayama J; Department of Rare Disease Genomics, Tohoku University Graduate School of Medicine, Miyagi, Japan.
  • Tamiya G; Department of AI and Innovative Medicine, Tohoku University Graduate School of Medicine, Miyagi, Japan.
  • Kure S; Statistical Genetics Team, RIKEN Center for Advanced Intelligence Project, Tokyo, Japan.
  • Kikuchi A; Department of Rare Disease Genomics, Tohoku University Graduate School of Medicine, Miyagi, Japan.
  • Sasahara Y; Department of AI and Innovative Medicine, Tohoku University Graduate School of Medicine, Miyagi, Japan.
Pediatr Hematol Oncol ; : 1-16, 2024 Sep 24.
Article in En | MEDLINE | ID: mdl-39318204
ABSTRACT
Persistent thrombocytopenia is caused by various diseases, including immune thrombocytopenia, inherited thrombocytopenia, and inherited bone marrow failure syndromes. Considering the large number of genes responsible for inherited disorders, comprehensive genetic analysis is required to diagnose monogenic disorders. In this study, we enrolled 53 pediatric patients with persistent thrombocytopenia exhibiting visually small or normal-sized platelets. We performed whole-exome sequencing, including 56 genes responsible for inherited thrombocytopenia, and evaluated clinical parameters according to disease type. Among 53 patients, 12 patients (22.6%) were diagnosed with monogenic disorders. Nine patients had a family history of thrombocytopenia. Pathogenic or novel variants of genes responsible for inherited thrombocytopenia were identified in three and six patients, respectively. The variants in genes for inherited thrombocytopenia with large or giant platelets were unexpectedly identified in six patients. Pathogenic variants in genes for inherited bone marrow failure syndromes with systemic features were identified in three patients with atypical symptoms. Since the definitive diagnostic methods for immune thrombocytopenia are limited, and a substantial number of patients with inherited thrombocytopenia are at a high risk of developing malignancies, comprehensive genetic analysis is indispensable for selecting appropriate therapies, avoidance of unnecessary treatments for immune thrombocytopenia, and long-term follow-up of patients with inherited thrombocytopenia.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Pediatr Hematol Oncol Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Pediatr Hematol Oncol Year: 2024 Document type: Article